Evidence map›Paper›PMID 34714566›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2021

Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain-like Protease PL

Maria Gil-Moles, Sebastian Türck, Uttara Basu, Andrea Pettenuzzo, Saurav Bhattacharya, Ananthu Rajan, Xiang Ma, Rolf Büssing, Jessica Wölker, Hilke Burmeister and 31 more

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Au(I)-based compounds inhibit nsp14/nsp10 and nsp13 (helicase) to exert anti-SARS-CoV-2 properties.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Article
  9. Review
  10. Antibacterial and Anti-Influenza Activities ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 9 institutions in 6 countries.

Maria Gil-MolesInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Sebastian TürckInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Uttara BasuInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.ORCID http://orcid.org/0000-0002-0509-2421
Andrea PettenuzzoSchool of Chemistry, National University of Ireland Galway, University Road, H91 TK33, Galway, Ireland.ORCID http://orcid.org/0000-0002-1127-3894
Saurav BhattacharyaDepartment of Life Sciences and Chemistry, Jacobs University, Campus Ring 1, 28759, Bremen, Germany.ORCID http://orcid.org/0000-0002-3396-8312
Ananthu RajanDepartment of Life Sciences and Chemistry, Jacobs University, Campus Ring 1, 28759, Bremen, Germany.ORCID http://orcid.org/0000-0001-9079-178X
Xiang MaDepartment of Life Sciences and Chemistry, Jacobs University, Campus Ring 1, 28759, Bremen, Germany.
Rolf BüssingInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Jessica WölkerInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Hilke BurmeisterInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Henrik HoffmeisterInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Pia SchneebergInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Andre PrauseInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Petra LippmannInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.
Josephine Kusi-NimarkoDepartment of Chemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QJ, Brighton, East Sussex, UK.
Storm Hassell-HartDepartment of Chemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QJ, Brighton, East Sussex, UK.
Andrew McGownDepartment of Chemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QJ, Brighton, East Sussex, UK.
Daniel GuestDepartment of Chemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QJ, Brighton, East Sussex, UK.
Yan LinChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0001-7808-5444
Anna NotaroChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.
Robin VinckChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0002-2730-0121
Johannes KargesChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0001-5258-0260
Kevin CariouChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0002-5854-9632
Kun PengInstitut für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID http://orcid.org/0000-0001-6885-9899
Xue QinLCC-CNRS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Xing WangLCC-CNRS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Joanna SkibaFaculty of Chemistry, Department of Organic Chemistry, University of Łódź, Tamka 12, 91-403, Łódź, Poland.ORCID http://orcid.org/0000-0003-0014-8366
Łukasz SzczupakFaculty of Chemistry, Department of Organic Chemistry, University of Łódź, Tamka 12, 91-403, Łódź, Poland.ORCID http://orcid.org/0000-0002-2620-2466
Konrad KowalskiFaculty of Chemistry, Department of Organic Chemistry, University of Łódź, Tamka 12, 91-403, Łódź, Poland.ORCID http://orcid.org/0000-0003-0600-3205
Ulrich SchatzschneiderInstitut für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.
Catherine HemmertLCC-CNRS, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0002-8122-5177
Heinz GornitzkaLCC-CNRS, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0002-8838-5907
Elena R MilaevaDepartment of Medicinal Chemistry and Fine Organic Synthesis, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991, Moscow, Russia.ORCID http://orcid.org/0000-0002-5489-3866
Alexey A NazarovDepartment of Medicinal Chemistry and Fine Organic Synthesis, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991, Moscow, Russia.ORCID http://orcid.org/0000-0002-5821-1658
Gilles GasserChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0002-4244-5097
John SpencerDepartment of Chemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QJ, Brighton, East Sussex, UK.ORCID http://orcid.org/0000-0001-5231-8836
Luca RonconiSchool of Chemistry, National University of Ireland Galway, University Road, H91 TK33, Galway, Ireland.ORCID http://orcid.org/0000-0002-8420-8364
Ulrich KortzDepartment of Life Sciences and Chemistry, Jacobs University, Campus Ring 1, 28759, Bremen, Germany.ORCID http://orcid.org/0000-0002-5472-3058
Jindrich CinatlInstitute of Medical Virology, Universitätsklinikum Frankfurt, Paul-Ehrlich-Str. 40, 60596, Frankfurt, Germany.
Denisa BojkovaInstitute of Medical Virology, Universitätsklinikum Frankfurt, Paul-Ehrlich-Str. 40, 60596, Frankfurt, Germany.
Ingo OttInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.ORCID http://orcid.org/0000-0002-8087-4618
Technische Universität Braunschweig · DECentre National de la Recherche Scientifique · FRUniversity of Sussex · GBConstructor University · DEUniversity of Łódź · PLGoethe University Frankfurt · DELomonosov Moscow State University · RUOllscoil na Gaillimhe – University of Galway · IEUniversity of Würzburg · DE

Funding

European Research Council
6 · The paper itself

Abstract

The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS-CoV-2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain-like protease PL

Indexed as

SARS-CoV-2Angiotensin-Converting Enzyme 2Antiviral AgentsCoronavirus Papain-Like ProteasesSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Antiviral AgentsCoronavirus Papain-Like Proteasespapain-like protease, SARS-CoV-2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2gold, metallodrugsPLpropolyoxometalatesSARS-CoV-2silverspike proteintitanocene

Identifiers

PMID34714566
PMCPMC8653295
OpenAlexW3209412740

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.